NL

Nicole Lai

Health and Science Investor, Angel

London, England

Invests in

Stages:

  • Min Investment:

    $580,000.00
  • Max Investment:

    $4,600,000.00
  • Target Investment:

    $2,600,000.00

Work Experience

  • Investment Consultant

    2024

    Direct healthcare/deep tech growth investor and institutional LP fund investments

2022

  • Angel Investor

    2022

    Investments include: Crade.bio, Mytos, Enginzyme, Effra

2021 - 2023

  • Investor

    2021 - 2023

2019 - 2021

  • Investor

    2019 - 2021

2021 - 2021

  • Board Observer

    2021 - 2021

2020 - 2021

  • Investor

    2020 - 2021

2019 - 2021

  • Board Observer

    2019 - 2021

2019 - 2021

  • Board Observer

    2019 - 2021

2018 - 2019

  • Investor

    2018 - 2019

2017 - 2019

  • Partner Associate

    2017 - 2019

    Real is an early-stage venture capital firm that backs entrepreneurs and builds the ecosystems in which they thrive. Real backs world-class entrepreneurs building game-changing companies, connecting them to local and national ecosystems and helping guide them through their next stages of evolution. The firm invests throughout the life-cycle of early-stage companies and provides stage-appropriate capital and support for the founders it backs. Real believes that VCs should play a role in accelerating the creation of world-class tech ecosystems by providing support beyond the companies for whom it writes cheques. It’s this collaborative mindset that inspires Real to launch initiatives that lay, or build upon, the foundations of rapidly growing tech hubs in Canada, and wherever else the firm may go.